Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 19
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer
Dave Bloom
-
2025/11/21
Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years
Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children
RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food Allergies
FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/22
0
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
News Wire ~ 3rd Party Press Release
-
2020/02/21
0
End Allergies Together Announces Winners of $1 Million Grand Challenge to...
News Wire ~ 3rd Party Press Release
-
2020/02/12
0
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
News Wire ~ 3rd Party Press Release
-
2020/02/06
0
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
News Wire ~ 3rd Party Press Release
-
2020/02/05
0
What You Need to Know About the First Peanut Allergy Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/03
0
FDA Approves Aimmune’s PALFORZIA as First Treatment for Peanut Allergy
News Wire ~ 3rd Party Press Release
-
2020/01/31
0
Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate
News Wire ~ 3rd Party Press Release
-
2020/01/29
0
Intrommune’s Food Allergy Toothpaste Therapy to Advance to Clinical Trials
Dave Bloom
-
2020/01/14
0
DBV Technologies Reports Positive Three-Year, Long Term Data from Phase III...
News Wire ~ 3rd Party Press Release
-
2020/01/09
0
1
...
18
19
20
...
30
Page 19 of 30